img

Global Pemetrexed Injection Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pemetrexed Injection Market Insights, Forecast to 2034

Pemetrexed is an antifolate agent with pyrrolidine pyrimidine group at its core. It can inhibit the growth of tumor by disrupting the normal folate dependent metabolic process in cells and inhibiting cell replication.
Global Pemetrexed Injection market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Pemetrexed Injection industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
Report Covers
This report presents an overview of global Pemetrexed Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Pemetrexed Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Eagle Pharmaceuticals
AuroMedics Pharma
Teva Pharmaceutical Industries
Taro Pharma
Seacross Pharmaceuticals
Simcere Pharmaceutical Group
Qilu Pharmaceutical
Pfizer
Jiangsu Anda Pharmaceutical
Yangtze River Pharmaceutical Group
Hansoh Pharmaceutical Group Company
Nanjing Pharmaceutical Factory
DEYAO PHARMA
Vianex S.A.-Plant C
Hainan Jinrui Pharmaceutical
Segment by Type
0.5g Bottle
0.2g Bottle

Segment by Application


Non Squamous Non-Small Cell Lung Cancer
Squamous Cell Non-Small Cell Lung Cancer

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Pemetrexed Injection plant distribution, commercial date of Pemetrexed Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Pemetrexed Injection introduction, etc. Pemetrexed Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Pemetrexed Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Pemetrexed Injection Product Introduction
1.2 Market by Type
1.2.1 Global Pemetrexed Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 0.5g Bottle
1.2.3 0.2g Bottle
1.3 Market by Application
1.3.1 Global Pemetrexed Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Non Squamous Non-Small Cell Lung Cancer
1.3.3 Squamous Cell Non-Small Cell Lung Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pemetrexed Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Pemetrexed Injection Revenue by Region
2.2.1 Global Pemetrexed Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pemetrexed Injection Revenue by Region (2018-2024)
2.2.3 Global Pemetrexed Injection Revenue by Region (2024-2029)
2.2.4 Global Pemetrexed Injection Revenue Market Share by Region (2018-2029)
2.3 Global Pemetrexed Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Pemetrexed Injection Sales by Region
2.4.1 Global Pemetrexed Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pemetrexed Injection Sales by Region (2018-2024)
2.4.3 Global Pemetrexed Injection Sales by Region (2024-2029)
2.4.4 Global Pemetrexed Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pemetrexed Injection Sales by Manufacturers
3.1.1 Global Pemetrexed Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Pemetrexed Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pemetrexed Injection in 2022
3.2 Global Pemetrexed Injection Revenue by Manufacturers
3.2.1 Global Pemetrexed Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Pemetrexed Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pemetrexed Injection Revenue in 2022
3.3 Global Key Players of Pemetrexed Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Pemetrexed Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pemetrexed Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pemetrexed Injection, Product Offered and Application
3.8 Global Key Manufacturers of Pemetrexed Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pemetrexed Injection Sales by Type
4.1.1 Global Pemetrexed Injection Historical Sales by Type (2018-2024)
4.1.2 Global Pemetrexed Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Pemetrexed Injection Sales Market Share by Type (2018-2029)
4.2 Global Pemetrexed Injection Revenue by Type
4.2.1 Global Pemetrexed Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Pemetrexed Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pemetrexed Injection Revenue Market Share by Type (2018-2029)
4.3 Global Pemetrexed Injection Price by Type
4.3.1 Global Pemetrexed Injection Price by Type (2018-2024)
4.3.2 Global Pemetrexed Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pemetrexed Injection Sales by Application
5.1.1 Global Pemetrexed Injection Historical Sales by Application (2018-2024)
5.1.2 Global Pemetrexed Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Pemetrexed Injection Sales Market Share by Application (2018-2029)
5.2 Global Pemetrexed Injection Revenue by Application
5.2.1 Global Pemetrexed Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Pemetrexed Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pemetrexed Injection Revenue Market Share by Application (2018-2029)
5.3 Global Pemetrexed Injection Price by Application
5.3.1 Global Pemetrexed Injection Price by Application (2018-2024)
5.3.2 Global Pemetrexed Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pemetrexed Injection Market Size by Type
6.1.1 US & Canada Pemetrexed Injection Sales by Type (2018-2029)
6.1.2 US & Canada Pemetrexed Injection Revenue by Type (2018-2029)
6.2 US & Canada Pemetrexed Injection Market Size by Application
6.2.1 US & Canada Pemetrexed Injection Sales by Application (2018-2029)
6.2.2 US & Canada Pemetrexed Injection Revenue by Application (2018-2029)
6.3 US & Canada Pemetrexed Injection Market Size by Country
6.3.1 US & Canada Pemetrexed Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pemetrexed Injection Sales by Country (2018-2029)
6.3.3 US & Canada Pemetrexed Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pemetrexed Injection Market Size by Type
7.1.1 Europe Pemetrexed Injection Sales by Type (2018-2029)
7.1.2 Europe Pemetrexed Injection Revenue by Type (2018-2029)
7.2 Europe Pemetrexed Injection Market Size by Application
7.2.1 Europe Pemetrexed Injection Sales by Application (2018-2029)
7.2.2 Europe Pemetrexed Injection Revenue by Application (2018-2029)
7.3 Europe Pemetrexed Injection Market Size by Country
7.3.1 Europe Pemetrexed Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pemetrexed Injection Sales by Country (2018-2029)
7.3.3 Europe Pemetrexed Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pemetrexed Injection Market Size
8.1.1 China Pemetrexed Injection Sales (2018-2029)
8.1.2 China Pemetrexed Injection Revenue (2018-2029)
8.2 China Pemetrexed Injection Market Size by Application
8.2.1 China Pemetrexed Injection Sales by Application (2018-2029)
8.2.2 China Pemetrexed Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pemetrexed Injection Market Size by Type
9.1.1 Asia Pemetrexed Injection Sales by Type (2018-2029)
9.1.2 Asia Pemetrexed Injection Revenue by Type (2018-2029)
9.2 Asia Pemetrexed Injection Market Size by Application
9.2.1 Asia Pemetrexed Injection Sales by Application (2018-2029)
9.2.2 Asia Pemetrexed Injection Revenue by Application (2018-2029)
9.3 Asia Pemetrexed Injection Sales by Region
9.3.1 Asia Pemetrexed Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pemetrexed Injection Revenue by Region (2018-2029)
9.3.3 Asia Pemetrexed Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pemetrexed Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Pemetrexed Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pemetrexed Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pemetrexed Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Pemetrexed Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pemetrexed Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pemetrexed Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Pemetrexed Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pemetrexed Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pemetrexed Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eagle Pharmaceuticals
11.1.1 Eagle Pharmaceuticals Company Information
11.1.2 Eagle Pharmaceuticals Overview
11.1.3 Eagle Pharmaceuticals Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Eagle Pharmaceuticals Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eagle Pharmaceuticals Recent Developments
11.2 AuroMedics Pharma
11.2.1 AuroMedics Pharma Company Information
11.2.2 AuroMedics Pharma Overview
11.2.3 AuroMedics Pharma Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AuroMedics Pharma Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AuroMedics Pharma Recent Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries Overview
11.3.3 Teva Pharmaceutical Industries Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Pharmaceutical Industries Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Pharmaceutical Industries Recent Developments
11.4 Taro Pharma
11.4.1 Taro Pharma Company Information
11.4.2 Taro Pharma Overview
11.4.3 Taro Pharma Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Taro Pharma Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Taro Pharma Recent Developments
11.5 Seacross Pharmaceuticals
11.5.1 Seacross Pharmaceuticals Company Information
11.5.2 Seacross Pharmaceuticals Overview
11.5.3 Seacross Pharmaceuticals Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Seacross Pharmaceuticals Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Seacross Pharmaceuticals Recent Developments
11.6 Simcere Pharmaceutical Group
11.6.1 Simcere Pharmaceutical Group Company Information
11.6.2 Simcere Pharmaceutical Group Overview
11.6.3 Simcere Pharmaceutical Group Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Simcere Pharmaceutical Group Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Simcere Pharmaceutical Group Recent Developments
11.7 Qilu Pharmaceutical
11.7.1 Qilu Pharmaceutical Company Information
11.7.2 Qilu Pharmaceutical Overview
11.7.3 Qilu Pharmaceutical Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Qilu Pharmaceutical Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qilu Pharmaceutical Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Pfizer Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Jiangsu Anda Pharmaceutical
11.9.1 Jiangsu Anda Pharmaceutical Company Information
11.9.2 Jiangsu Anda Pharmaceutical Overview
11.9.3 Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu Anda Pharmaceutical Recent Developments
11.10 Yangtze River Pharmaceutical Group
11.10.1 Yangtze River Pharmaceutical Group Company Information
11.10.2 Yangtze River Pharmaceutical Group Overview
11.10.3 Yangtze River Pharmaceutical Group Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Yangtze River Pharmaceutical Group Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yangtze River Pharmaceutical Group Recent Developments
11.11 Hansoh Pharmaceutical Group Company
11.11.1 Hansoh Pharmaceutical Group Company Company Information
11.11.2 Hansoh Pharmaceutical Group Company Overview
11.11.3 Hansoh Pharmaceutical Group Company Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hansoh Pharmaceutical Group Company Recent Developments
11.12 Nanjing Pharmaceutical Factory
11.12.1 Nanjing Pharmaceutical Factory Company Information
11.12.2 Nanjing Pharmaceutical Factory Overview
11.12.3 Nanjing Pharmaceutical Factory Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Nanjing Pharmaceutical Factory Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Nanjing Pharmaceutical Factory Recent Developments
11.13 DEYAO PHARMA
11.13.1 DEYAO PHARMA Company Information
11.13.2 DEYAO PHARMA Overview
11.13.3 DEYAO PHARMA Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 DEYAO PHARMA Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 DEYAO PHARMA Recent Developments
11.14 Vianex S.A.-Plant C
11.14.1 Vianex S.A.-Plant C Company Information
11.14.2 Vianex S.A.-Plant C Overview
11.14.3 Vianex S.A.-Plant C Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Vianex S.A.-Plant C Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Vianex S.A.-Plant C Recent Developments
11.15 Hainan Jinrui Pharmaceutical
11.15.1 Hainan Jinrui Pharmaceutical Company Information
11.15.2 Hainan Jinrui Pharmaceutical Overview
11.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hainan Jinrui Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pemetrexed Injection Industry Chain Analysis
12.2 Pemetrexed Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pemetrexed Injection Production Mode & Process
12.4 Pemetrexed Injection Sales and Marketing
12.4.1 Pemetrexed Injection Sales Channels
12.4.2 Pemetrexed Injection Distributors
12.5 Pemetrexed Injection Customers
13 Market Dynamics
13.1 Pemetrexed Injection Industry Trends
13.2 Pemetrexed Injection Market Drivers
13.3 Pemetrexed Injection Market Challenges
13.4 Pemetrexed Injection Market Restraints
14 Key Findings in The Global Pemetrexed Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pemetrexed Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 0.5g Bottle
Table 3. Major Manufacturers of 0.2g Bottle
Table 4. Global Pemetrexed Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Pemetrexed Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Pemetrexed Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Pemetrexed Injection Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Pemetrexed Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Pemetrexed Injection Revenue Market Share by Region (2024-2029)
Table 10. Global Pemetrexed Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Pemetrexed Injection Sales by Region (2018-2024) & (K Units)
Table 12. Global Pemetrexed Injection Sales by Region (2024-2029) & (K Units)
Table 13. Global Pemetrexed Injection Sales Market Share by Region (2018-2024)
Table 14. Global Pemetrexed Injection Sales Market Share by Region (2024-2029)
Table 15. Global Pemetrexed Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Pemetrexed Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Pemetrexed Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Pemetrexed Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Pemetrexed Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Pemetrexed Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Pemetrexed Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pemetrexed Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Injection as of 2022)
Table 23. Global Key Manufacturers of Pemetrexed Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pemetrexed Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Pemetrexed Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pemetrexed Injection Sales by Type (2018-2024) & (K Units)
Table 28. Global Pemetrexed Injection Sales by Type (2024-2029) & (K Units)
Table 29. Global Pemetrexed Injection Sales Share by Type (2018-2024)
Table 30. Global Pemetrexed Injection Sales Share by Type (2024-2029)
Table 31. Global Pemetrexed Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Pemetrexed Injection Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Pemetrexed Injection Revenue Share by Type (2018-2024)
Table 34. Global Pemetrexed Injection Revenue Share by Type (2024-2029)
Table 35. Pemetrexed Injection Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Pemetrexed Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Pemetrexed Injection Sales by Application (2018-2024) & (K Units)
Table 38. Global Pemetrexed Injection Sales by Application (2024-2029) & (K Units)
Table 39. Global Pemetrexed Injection Sales Share by Application (2018-2024)
Table 40. Global Pemetrexed Injection Sales Share by Application (2024-2029)
Table 41. Global Pemetrexed Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Pemetrexed Injection Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Pemetrexed Injection Revenue Share by Application (2018-2024)
Table 44. Global Pemetrexed Injection Revenue Share by Application (2024-2029)
Table 45. Pemetrexed Injection Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Pemetrexed Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Pemetrexed Injection Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Pemetrexed Injection Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Pemetrexed Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Pemetrexed Injection Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Pemetrexed Injection Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Pemetrexed Injection Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Pemetrexed Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Pemetrexed Injection Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Pemetrexed Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Pemetrexed Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Pemetrexed Injection Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Pemetrexed Injection Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Pemetrexed Injection Sales by Country (2024-2029) & (K Units)
Table 60. Europe Pemetrexed Injection Sales by Type (2018-2024) & (K Units)
Table 61. Europe Pemetrexed Injection Sales by Type (2024-2029) & (K Units)
Table 62. Europe Pemetrexed Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Pemetrexed Injection Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Pemetrexed Injection Sales by Application (2018-2024) & (K Units)
Table 65. Europe Pemetrexed Injection Sales by Application (2024-2029) & (K Units)
Table 66. Europe Pemetrexed Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Pemetrexed Injection Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Pemetrexed Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Pemetrexed Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Pemetrexed Injection Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Pemetrexed Injection Sales by Country (2018-2024) & (K Units)
Table 72. Europe Pemetrexed Injection Sales by Country (2024-2029) & (K Units)
Table 73. China Pemetrexed Injection Sales by Type (2018-2024) & (K Units)
Table 74. China Pemetrexed Injection Sales by Type (2024-2029) & (K Units)
Table 75. China Pemetrexed Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Pemetrexed Injection Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Pemetrexed Injection Sales by Application (2018-2024) & (K Units)
Table 78. China Pemetrexed Injection Sales by Application (2024-2029) & (K Units)
Table 79. China Pemetrexed Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Pemetrexed Injection Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Pemetrexed Injection Sales by Type (2018-2024) & (K Units)
Table 82. Asia Pemetrexed Injection Sales by Type (2024-2029) & (K Units)
Table 83. Asia Pemetrexed Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Pemetrexed Injection Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Pemetrexed Injection Sales by Application (2018-2024) & (K Units)
Table 86. Asia Pemetrexed Injection Sales by Application (2024-2029) & (K Units)
Table 87. Asia Pemetrexed Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Pemetrexed Injection Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Pemetrexed Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Pemetrexed Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Pemetrexed Injection Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Pemetrexed Injection Sales by Region (2018-2024) & (K Units)
Table 93. Asia Pemetrexed Injection Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Pemetrexed Injection Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Pemetrexed Injection Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Pemetrexed Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Pemetrexed Injection Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pemetrexed Injection Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Pemetrexed Injection Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Pemetrexed Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pemetrexed Injection Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pemetrexed Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Pemetrexed Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pemetrexed Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pemetrexed Injection Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Pemetrexed Injection Sales by Country (2024-2029) & (K Units)
Table 107. Eagle Pharmaceuticals Company Information
Table 108. Eagle Pharmaceuticals Description and Major Businesses
Table 109. Eagle Pharmaceuticals Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Eagle Pharmaceuticals Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Eagle Pharmaceuticals Recent Developments
Table 112. AuroMedics Pharma Company Information
Table 113. AuroMedics Pharma Description and Major Businesses
Table 114. AuroMedics Pharma Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. AuroMedics Pharma Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. AuroMedics Pharma Recent Developments
Table 117. Teva Pharmaceutical Industries Company Information
Table 118. Teva Pharmaceutical Industries Description and Major Businesses
Table 119. Teva Pharmaceutical Industries Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Teva Pharmaceutical Industries Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Pharmaceutical Industries Recent Developments
Table 122. Taro Pharma Company Information
Table 123. Taro Pharma Description and Major Businesses
Table 124. Taro Pharma Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Taro Pharma Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Taro Pharma Recent Developments
Table 127. Seacross Pharmaceuticals Company Information
Table 128. Seacross Pharmaceuticals Description and Major Businesses
Table 129. Seacross Pharmaceuticals Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Seacross Pharmaceuticals Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Seacross Pharmaceuticals Recent Developments
Table 132. Simcere Pharmaceutical Group Company Information
Table 133. Simcere Pharmaceutical Group Description and Major Businesses
Table 134. Simcere Pharmaceutical Group Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Simcere Pharmaceutical Group Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Simcere Pharmaceutical Group Recent Developments
Table 137. Qilu Pharmaceutical Company Information
Table 138. Qilu Pharmaceutical Description and Major Businesses
Table 139. Qilu Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Qilu Pharmaceutical Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Qilu Pharmaceutical Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Pfizer Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. Jiangsu Anda Pharmaceutical Company Information
Table 148. Jiangsu Anda Pharmaceutical Description and Major Businesses
Table 149. Jiangsu Anda Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Jiangsu Anda Pharmaceutical Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Jiangsu Anda Pharmaceutical Recent Developments
Table 152. Yangtze River Pharmaceutical Group Company Information
Table 153. Yangtze River Pharmaceutical Group Description and Major Businesses
Table 154. Yangtze River Pharmaceutical Group Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Yangtze River Pharmaceutical Group Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Yangtze River Pharmaceutical Group Recent Developments
Table 157. Hansoh Pharmaceutical Group Company Company Information
Table 158. Hansoh Pharmaceutical Group Company Description and Major Businesses
Table 159. Hansoh Pharmaceutical Group Company Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Hansoh Pharmaceutical Group Company Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hansoh Pharmaceutical Group Company Recent Developments
Table 162. Nanjing Pharmaceutical Factory Company Information
Table 163. Nanjing Pharmaceutical Factory Description and Major Businesses
Table 164. Nanjing Pharmaceutical Factory Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Nanjing Pharmaceutical Factory Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Nanjing Pharmaceutical Factory Recent Developments
Table 167. DEYAO PHARMA Company Information
Table 168. DEYAO PHARMA Description and Major Businesses
Table 169. DEYAO PHARMA Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. DEYAO PHARMA Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. DEYAO PHARMA Recent Developments
Table 172. Vianex S.A.-Plant C Company Information
Table 173. Vianex S.A.-Plant C Description and Major Businesses
Table 174. Vianex S.A.-Plant C Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Vianex S.A.-Plant C Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Vianex S.A.-Plant C Recent Developments
Table 177. Hainan Jinrui Pharmaceutical Company Information
Table 178. Hainan Jinrui Pharmaceutical Description and Major Businesses
Table 179. Hainan Jinrui Pharmaceutical Pemetrexed Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Hainan Jinrui Pharmaceutical Pemetrexed Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Hainan Jinrui Pharmaceutical Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Pemetrexed Injection Distributors List
Table 185. Pemetrexed Injection Customers List
Table 186. Pemetrexed Injection Market Trends
Table 187. Pemetrexed Injection Market Drivers
Table 188. Pemetrexed Injection Market Challenges
Table 189. Pemetrexed Injection Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Pemetrexed Injection Product Picture
Figure 2. Global Pemetrexed Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pemetrexed Injection Market Share by Type in 2022 & 2029
Figure 4. 0.5g Bottle Product Picture
Figure 5. 0.2g Bottle Product Picture
Figure 6. Global Pemetrexed Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Pemetrexed Injection Market Share by Application in 2022 & 2029
Figure 8. Non Squamous Non-Small Cell Lung Cancer
Figure 9. Squamous Cell Non-Small Cell Lung Cancer
Figure 10. Pemetrexed Injection Report Years Considered
Figure 11. Global Pemetrexed Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Pemetrexed Injection Revenue 2018-2029 (US$ Million)
Figure 13. Global Pemetrexed Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Pemetrexed Injection Revenue Market Share by Region (2018-2029)
Figure 15. Global Pemetrexed Injection Sales 2018-2029 ((K Units)
Figure 16. Global Pemetrexed Injection Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Pemetrexed Injection Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Pemetrexed Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Pemetrexed Injection Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Pemetrexed Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Pemetrexed Injection Sales YoY (2018-2029) & (K Units)
Figure 22. China Pemetrexed Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Pemetrexed Injection Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Pemetrexed Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Pemetrexed Injection Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Pemetrexed Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Pemetrexed Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Pemetrexed Injection in the World: Market Share by Pemetrexed Injection Revenue in 2022
Figure 29. Global Pemetrexed Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Pemetrexed Injection Sales Market Share by Type (2018-2029)
Figure 31. Global Pemetrexed Injection Revenue Market Share by Type (2018-2029)
Figure 32. Global Pemetrexed Injection Sales Market Share by Application (2018-2029)
Figure 33. Global Pemetrexed Injection Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Pemetrexed Injection Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Pemetrexed Injection Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Pemetrexed Injection Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Pemetrexed Injection Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Pemetrexed Injection Revenue Share by Country (2018-2029)
Figure 39. US & Canada Pemetrexed Injection Sales Share by Country (2018-2029)
Figure 40. U.S. Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Pemetrexed Injection Sales Market Share by Type (2018-2029)
Figure 43. Europe Pemetrexed Injection Revenue Market Share by Type (2018-2029)
Figure 44. Europe Pemetrexed Injection Sales Market Share by Application (2018-2029)
Figure 45. Europe Pemetrexed Injection Revenue Market Share by Application (2018-2029)
Figure 46. Europe Pemetrexed Injection Revenue Share by Country (2018-2029)
Figure 47. Europe Pemetrexed Injection Sales Share by Country (2018-2029)
Figure 48. Germany Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 49. France Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 53. China Pemetrexed Injection Sales Market Share by Type (2018-2029)
Figure 54. China Pemetrexed Injection Revenue Market Share by Type (2018-2029)
Figure 55. China Pemetrexed Injection Sales Market Share by Application (2018-2029)
Figure 56. China Pemetrexed Injection Revenue Market Share by Application (2018-2029)
Figure 57. Asia Pemetrexed Injection Sales Market Share by Type (2018-2029)
Figure 58. Asia Pemetrexed Injection Revenue Market Share by Type (2018-2029)
Figure 59. Asia Pemetrexed Injection Sales Market Share by Application (2018-2029)
Figure 60. Asia Pemetrexed Injection Revenue Market Share by Application (2018-2029)
Figure 61. Asia Pemetrexed Injection Revenue Share by Region (2018-2029)
Figure 62. Asia Pemetrexed Injection Sales Share by Region (2018-2029)
Figure 63. Japan Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 67. India Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Pemetrexed Injection Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Pemetrexed Injection Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Pemetrexed Injection Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Pemetrexed Injection Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Pemetrexed Injection Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Pemetrexed Injection Sales Share by Country (2018-2029)
Figure 74. Brazil Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Pemetrexed Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Pemetrexed Injection Value Chain
Figure 80. Pemetrexed Injection Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries